nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—RXRA—systemic lupus erythematosus	0.6	1	CbGaD
Bexarotene—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0306	0.174	CbGbCtD
Bexarotene—CYP2C9—Dapsone—systemic lupus erythematosus	0.0218	0.124	CbGbCtD
Bexarotene—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0145	0.0827	CbGbCtD
Bexarotene—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0143	0.0816	CbGbCtD
Bexarotene—CYP3A4—Dapsone—systemic lupus erythematosus	0.0127	0.0722	CbGbCtD
Bexarotene—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.011	0.0626	CbGbCtD
Bexarotene—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.011	0.0626	CbGbCtD
Bexarotene—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00942	0.0538	CbGbCtD
Bexarotene—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00942	0.0537	CbGbCtD
Bexarotene—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0093	0.053	CbGbCtD
Bexarotene—CYP2C9—cardial valve—systemic lupus erythematosus	0.00899	0.331	CbGeAlD
Bexarotene—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00881	0.0503	CbGbCtD
Bexarotene—CYP3A4—Prednisone—systemic lupus erythematosus	0.00878	0.0501	CbGbCtD
Bexarotene—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00832	0.0475	CbGbCtD
Bexarotene—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00548	0.0313	CbGbCtD
Bexarotene—RXRB—Vitamin D Metabolism—RXRA—systemic lupus erythematosus	0.002	0.0437	CbGpPWpGaD
Bexarotene—CYP2C9—urine—systemic lupus erythematosus	0.00194	0.0713	CbGeAlD
Bexarotene—RXRA—kidney—systemic lupus erythematosus	0.00189	0.0696	CbGeAlD
Bexarotene—RXRB—Vitamin D Metabolism—VDR—systemic lupus erythematosus	0.00181	0.0396	CbGpPWpGaD
Bexarotene—CYP3A4—urine—systemic lupus erythematosus	0.00148	0.0544	CbGeAlD
Bexarotene—RXRG—tendon—systemic lupus erythematosus	0.00134	0.0493	CbGeAlD
Bexarotene—RXRB—tendon—systemic lupus erythematosus	0.00126	0.0464	CbGeAlD
Bexarotene—RXRA—nervous system—systemic lupus erythematosus	0.00124	0.0457	CbGeAlD
Bexarotene—RXRA—central nervous system—systemic lupus erythematosus	0.0012	0.044	CbGeAlD
Bexarotene—RXRB—lung—systemic lupus erythematosus	0.00111	0.0407	CbGeAlD
Bexarotene—RXRG—nervous system—systemic lupus erythematosus	0.00109	0.0401	CbGeAlD
Bexarotene—RXRG—central nervous system—systemic lupus erythematosus	0.00105	0.0386	CbGeAlD
Bexarotene—RXRB—nervous system—systemic lupus erythematosus	0.00102	0.0377	CbGeAlD
Bexarotene—CYP2C9—blood plasma—systemic lupus erythematosus	0.00101	0.0372	CbGeAlD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000992	0.0216	CbGpPWpGaD
Bexarotene—RXRB—central nervous system—systemic lupus erythematosus	0.000987	0.0363	CbGeAlD
Bexarotene—RXRA—Vitamin D Metabolism—VDR—systemic lupus erythematosus	0.000945	0.0206	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000932	0.0203	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000898	0.0196	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—RXRA—systemic lupus erythematosus	0.000884	0.0193	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000844	0.0184	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—RXRA—systemic lupus erythematosus	0.000831	0.0181	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000801	0.0175	CbGpPWpGaD
Bexarotene—CYP3A4—blood plasma—systemic lupus erythematosus	0.000772	0.0284	CbGeAlD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000753	0.0164	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000732	0.016	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000688	0.015	CbGpPWpGaD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—RXRA—systemic lupus erythematosus	0.000663	0.0145	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000663	0.0145	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000648	0.0141	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—RXRA—systemic lupus erythematosus	0.000639	0.014	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000626	0.0137	CbGpPWpGaD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—RXRA—systemic lupus erythematosus	0.000623	0.0136	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000623	0.0136	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—RXRA—systemic lupus erythematosus	0.000601	0.0131	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000597	0.013	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000589	0.0128	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000578	0.0126	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000561	0.0122	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000561	0.0122	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000544	0.0119	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000527	0.0115	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000524	0.0114	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000493	0.0107	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000472	0.0103	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000462	0.0101	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	0.000457	0.00998	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—NR3C1—systemic lupus erythematosus	0.000453	0.00988	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000443	0.00967	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.00044	0.0096	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000435	0.00948	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	0.00043	0.00938	CbGpPWpGaD
Bexarotene—RXRA—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000407	0.00888	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000392	0.00856	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.000365	0.00797	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000365	0.00797	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000356	0.00777	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—PPARG—systemic lupus erythematosus	0.000351	0.00765	CbGpPWpGaD
Bexarotene—CYP3A4—kidney—systemic lupus erythematosus	0.00035	0.0129	CbGeAlD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.000343	0.00749	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000343	0.00749	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000335	0.00731	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000333	0.00726	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—GADD45A—systemic lupus erythematosus	0.000331	0.00722	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000325	0.00709	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000319	0.00697	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000313	0.00682	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000307	0.00669	CbGpPWpGaD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR3C1—systemic lupus erythematosus	0.000299	0.00652	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000292	0.00638	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—RXRA—systemic lupus erythematosus	0.000274	0.00597	CbGpPWpGaD
Bexarotene—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000257	0.00561	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000257	0.0056	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—systemic lupus erythematosus	0.000238	0.00519	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	0.000232	0.00506	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000231	0.00504	CbGpPWpGaD
Bexarotene—CYP3A4—nervous system—systemic lupus erythematosus	0.00023	0.00844	CbGeAlD
Bexarotene—RXRA—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000226	0.00494	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	0.000224	0.00489	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—NR3C1—systemic lupus erythematosus	0.000223	0.00487	CbGpPWpGaD
Bexarotene—CYP3A4—central nervous system—systemic lupus erythematosus	0.000221	0.00813	CbGeAlD
Bexarotene—RXRB—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	0.000218	0.00475	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—NR3C1—systemic lupus erythematosus	0.000218	0.00475	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—FAS—systemic lupus erythematosus	0.000216	0.00472	CbGpPWpGaD
Bexarotene—RXRA—REV-ERBA represses gene expression—EP300—systemic lupus erythematosus	0.000214	0.00467	CbGpPWpGaD
Bexarotene—RXRA—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000213	0.00464	CbGpPWpGaD
Bexarotene—RXRA—RORA activates circadian gene expression—EP300—systemic lupus erythematosus	0.000207	0.00452	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—NAT2—systemic lupus erythematosus	0.000191	0.00417	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—systemic lupus erythematosus	0.000186	0.00406	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.000179	0.00391	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000179	0.0039	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000174	0.00381	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—PPARG—systemic lupus erythematosus	0.000173	0.00377	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000165	0.0036	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000163	0.00355	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—GADD45A—systemic lupus erythematosus	0.000162	0.00354	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000156	0.00341	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000155	0.00339	CbGpPWpGaD
Bexarotene—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000154	0.00335	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000154	0.00335	CbGpPWpGaD
Bexarotene—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000154	0.00335	CbGpPWpGaD
Bexarotene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000152	0.00332	CbGpPWpGaD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—systemic lupus erythematosus	0.000151	0.0033	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—IL6—systemic lupus erythematosus	0.00015	0.00328	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MTA2—systemic lupus erythematosus	0.000149	0.00326	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MTA2—systemic lupus erythematosus	0.00014	0.00307	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000133	0.00289	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—systemic lupus erythematosus	0.000129	0.00281	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000119	0.0026	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—CDKN1A—systemic lupus erythematosus	0.000119	0.00259	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000114	0.00249	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	0.000114	0.00248	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000112	0.00245	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—EP300—systemic lupus erythematosus	0.00011	0.00241	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—NR3C1—systemic lupus erythematosus	0.000109	0.00238	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000107	0.00234	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—FAS—systemic lupus erythematosus	0.000106	0.00231	CbGpPWpGaD
Bexarotene—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000101	0.00221	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000101	0.0022	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	9.99e-05	0.00218	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—systemic lupus erythematosus	9.83e-05	0.00214	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SNRPB—systemic lupus erythematosus	9.77e-05	0.00213	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—PPARG—systemic lupus erythematosus	9.68e-05	0.00211	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—TNFSF13—systemic lupus erythematosus	9.49e-05	0.00207	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	9.47e-05	0.00207	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	9.39e-05	0.00205	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	9.29e-05	0.00203	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	9.24e-05	0.00202	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SNRPB—systemic lupus erythematosus	9.19e-05	0.00201	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—systemic lupus erythematosus	9.18e-05	0.002	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	9.05e-05	0.00197	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	8.74e-05	0.00191	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—VDR—systemic lupus erythematosus	8.51e-05	0.00186	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—PPARG—systemic lupus erythematosus	8.47e-05	0.00185	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	8.42e-05	0.00184	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	8.15e-05	0.00178	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SNRPD1—systemic lupus erythematosus	8.1e-05	0.00177	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	8.07e-05	0.00176	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	7.85e-05	0.00171	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	7.78e-05	0.0017	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	7.66e-05	0.00167	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	7.53e-05	0.00164	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—systemic lupus erythematosus	7.4e-05	0.00162	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HIST2H2AC—systemic lupus erythematosus	7.38e-05	0.00161	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MTA2—systemic lupus erythematosus	7.32e-05	0.0016	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	7.32e-05	0.0016	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	7.14e-05	0.00156	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	7.04e-05	0.00154	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	6.84e-05	0.00149	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LYN—systemic lupus erythematosus	6.66e-05	0.00145	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	6.53e-05	0.00142	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—EP300—systemic lupus erythematosus	6.33e-05	0.00138	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	6.31e-05	0.00138	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	6.2e-05	0.00135	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.13e-05	0.00134	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.09e-05	0.00133	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.93e-05	0.00129	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CDKN1A—systemic lupus erythematosus	5.82e-05	0.00127	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PTPRC—systemic lupus erythematosus	5.7e-05	0.00124	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	5.59e-05	0.00122	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—JUNB—systemic lupus erythematosus	5.49e-05	0.0012	CbGpPWpGaD
Bexarotene—Myalgia—Dexamethasone—systemic lupus erythematosus	5.41e-05	0.000358	CcSEcCtD
Bexarotene—Body temperature increased—Cyclosporine—systemic lupus erythematosus	5.4e-05	0.000357	CcSEcCtD
Bexarotene—Abdominal pain—Cyclosporine—systemic lupus erythematosus	5.4e-05	0.000357	CcSEcCtD
Bexarotene—Anxiety—Dexamethasone—systemic lupus erythematosus	5.39e-05	0.000356	CcSEcCtD
Bexarotene—Anxiety—Betamethasone—systemic lupus erythematosus	5.39e-05	0.000356	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—ADIPOQ—systemic lupus erythematosus	5.38e-05	0.00117	CbGpPWpGaD
Bexarotene—Discomfort—Betamethasone—systemic lupus erythematosus	5.35e-05	0.000353	CcSEcCtD
Bexarotene—Discomfort—Dexamethasone—systemic lupus erythematosus	5.35e-05	0.000353	CcSEcCtD
Bexarotene—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	5.35e-05	0.000353	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—systemic lupus erythematosus	5.34e-05	0.000353	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.34e-05	0.00117	CbGpPWpGaD
Bexarotene—Pain—Prednisolone—systemic lupus erythematosus	5.32e-05	0.000351	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—systemic lupus erythematosus	5.32e-05	0.000351	CcSEcCtD
Bexarotene—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	5.28e-05	0.000349	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—systemic lupus erythematosus	5.28e-05	0.000348	CcSEcCtD
Bexarotene—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.27e-05	0.000348	CcSEcCtD
Bexarotene—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.27e-05	0.000348	CcSEcCtD
Bexarotene—Nausea—Leflunomide—systemic lupus erythematosus	5.26e-05	0.000347	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	5.25e-05	0.000347	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	5.24e-05	0.000346	CcSEcCtD
Bexarotene—Fatigue—Hydrocortisone—systemic lupus erythematosus	5.24e-05	0.000346	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—systemic lupus erythematosus	5.21e-05	0.000344	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.21e-05	0.000344	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5.2e-05	0.000343	CcSEcCtD
Bexarotene—Pain—Hydrocortisone—systemic lupus erythematosus	5.19e-05	0.000343	CcSEcCtD
Bexarotene—Oedema—Betamethasone—systemic lupus erythematosus	5.19e-05	0.000343	CcSEcCtD
Bexarotene—Oedema—Dexamethasone—systemic lupus erythematosus	5.19e-05	0.000343	CcSEcCtD
Bexarotene—Insomnia—Triamcinolone—systemic lupus erythematosus	5.17e-05	0.000342	CcSEcCtD
Bexarotene—RXRB—Gene Expression—JUNB—systemic lupus erythematosus	5.16e-05	0.00113	CbGpPWpGaD
Bexarotene—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.16e-05	0.000341	CcSEcCtD
Bexarotene—Infection—Betamethasone—systemic lupus erythematosus	5.15e-05	0.000341	CcSEcCtD
Bexarotene—Infection—Dexamethasone—systemic lupus erythematosus	5.15e-05	0.000341	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—systemic lupus erythematosus	5.14e-05	0.000339	CcSEcCtD
Bexarotene—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.14e-05	0.000339	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisolone—systemic lupus erythematosus	5.12e-05	0.000338	CcSEcCtD
Bexarotene—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.12e-05	0.000338	CcSEcCtD
Bexarotene—Anaemia—Prednisone—systemic lupus erythematosus	5.12e-05	0.000338	CcSEcCtD
Bexarotene—Shock—Dexamethasone—systemic lupus erythematosus	5.1e-05	0.000337	CcSEcCtD
Bexarotene—Shock—Betamethasone—systemic lupus erythematosus	5.1e-05	0.000337	CcSEcCtD
Bexarotene—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.1e-05	0.000337	CcSEcCtD
Bexarotene—Nervous system disorder—Betamethasone—systemic lupus erythematosus	5.09e-05	0.000336	CcSEcCtD
Bexarotene—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	5.09e-05	0.000336	CcSEcCtD
Bexarotene—Agitation—Prednisone—systemic lupus erythematosus	5.09e-05	0.000336	CcSEcCtD
Bexarotene—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.08e-05	0.000336	CcSEcCtD
Bexarotene—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.08e-05	0.000336	CcSEcCtD
Bexarotene—Tachycardia—Betamethasone—systemic lupus erythematosus	5.06e-05	0.000335	CcSEcCtD
Bexarotene—Tachycardia—Dexamethasone—systemic lupus erythematosus	5.06e-05	0.000335	CcSEcCtD
Bexarotene—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	5.03e-05	0.000333	CcSEcCtD
Bexarotene—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.03e-05	0.000333	CcSEcCtD
Bexarotene—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.02e-05	0.000332	CcSEcCtD
Bexarotene—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	5.02e-05	0.000331	CcSEcCtD
Bexarotene—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	5.02e-05	0.000331	CcSEcCtD
Bexarotene—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	5e-05	0.000331	CcSEcCtD
Bexarotene—Malaise—Prednisone—systemic lupus erythematosus	4.99e-05	0.00033	CcSEcCtD
Bexarotene—Vertigo—Prednisone—systemic lupus erythematosus	4.97e-05	0.000329	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.97e-05	0.00108	CbGpPWpGaD
Bexarotene—Eye disorder—Methotrexate—systemic lupus erythematosus	4.97e-05	0.000328	CcSEcCtD
Bexarotene—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.97e-05	0.000328	CcSEcCtD
Bexarotene—Syncope—Prednisone—systemic lupus erythematosus	4.97e-05	0.000328	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—systemic lupus erythematosus	4.96e-05	0.000327	CcSEcCtD
Bexarotene—Anorexia—Dexamethasone—systemic lupus erythematosus	4.95e-05	0.000327	CcSEcCtD
Bexarotene—Anorexia—Betamethasone—systemic lupus erythematosus	4.95e-05	0.000327	CcSEcCtD
Bexarotene—RXRA—Gene Expression—TNFSF13—systemic lupus erythematosus	4.95e-05	0.00108	CbGpPWpGaD
Bexarotene—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.93e-05	0.000326	CcSEcCtD
Bexarotene—Fatigue—Triamcinolone—systemic lupus erythematosus	4.93e-05	0.000326	CcSEcCtD
Bexarotene—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.92e-05	0.000325	CcSEcCtD
Bexarotene—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.91e-05	0.000324	CcSEcCtD
Bexarotene—Asthenia—Cyclosporine—systemic lupus erythematosus	4.9e-05	0.000324	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.9e-05	0.00107	CbGpPWpGaD
Bexarotene—Pain—Triamcinolone—systemic lupus erythematosus	4.89e-05	0.000323	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.87e-05	0.000321	CcSEcCtD
Bexarotene—Pruritus—Cyclosporine—systemic lupus erythematosus	4.83e-05	0.000319	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—systemic lupus erythematosus	4.82e-05	0.000319	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TGFB1—systemic lupus erythematosus	4.81e-05	0.00105	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—RXRA—systemic lupus erythematosus	4.81e-05	0.00105	CbGpPWpGaD
Bexarotene—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.8e-05	0.000317	CcSEcCtD
Bexarotene—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.8e-05	0.000317	CcSEcCtD
Bexarotene—RXRA—Gene Expression—SNRPB—systemic lupus erythematosus	4.79e-05	0.00105	CbGpPWpGaD
Bexarotene—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.78e-05	0.000316	CcSEcCtD
Bexarotene—Hypertension—Prednisone—systemic lupus erythematosus	4.78e-05	0.000316	CcSEcCtD
Bexarotene—Chills—Methotrexate—systemic lupus erythematosus	4.77e-05	0.000315	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.73e-05	0.000312	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.73e-05	0.000312	CcSEcCtD
Bexarotene—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.72e-05	0.000312	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—systemic lupus erythematosus	4.71e-05	0.000311	CcSEcCtD
Bexarotene—Myalgia—Prednisone—systemic lupus erythematosus	4.71e-05	0.000311	CcSEcCtD
Bexarotene—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.71e-05	0.000311	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	4.71e-05	0.00103	CbGpPWpGaD
Bexarotene—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.7e-05	0.000311	CcSEcCtD
Bexarotene—Anxiety—Prednisone—systemic lupus erythematosus	4.7e-05	0.00031	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—systemic lupus erythematosus	4.7e-05	0.00031	CcSEcCtD
Bexarotene—Insomnia—Dexamethasone—systemic lupus erythematosus	4.69e-05	0.00031	CcSEcCtD
Bexarotene—Insomnia—Betamethasone—systemic lupus erythematosus	4.69e-05	0.00031	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.68e-05	0.000309	CcSEcCtD
Bexarotene—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.68e-05	0.000309	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.67e-05	0.000308	CcSEcCtD
Bexarotene—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.66e-05	0.000308	CcSEcCtD
Bexarotene—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.66e-05	0.000308	CcSEcCtD
Bexarotene—Discomfort—Prednisone—systemic lupus erythematosus	4.66e-05	0.000308	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.64e-05	0.00101	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.64e-05	0.00101	CbGpPWpGaD
Bexarotene—Malnutrition—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000306	CcSEcCtD
Bexarotene—Erythema—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000306	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.58e-05	0.000303	CcSEcCtD
Bexarotene—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.57e-05	0.000302	CcSEcCtD
Bexarotene—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.57e-05	0.000302	CcSEcCtD
Bexarotene—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.56e-05	0.000301	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000299	CcSEcCtD
Bexarotene—RXRB—Gene Expression—RXRA—systemic lupus erythematosus	4.52e-05	0.000987	CbGpPWpGaD
Bexarotene—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.52e-05	0.000299	CcSEcCtD
Bexarotene—Dizziness—Cyclosporine—systemic lupus erythematosus	4.52e-05	0.000298	CcSEcCtD
Bexarotene—Oedema—Prednisone—systemic lupus erythematosus	4.52e-05	0.000298	CcSEcCtD
Bexarotene—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.51e-05	0.000298	CcSEcCtD
Bexarotene—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.51e-05	0.000298	CcSEcCtD
Bexarotene—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.51e-05	0.000298	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TNF—systemic lupus erythematosus	4.5e-05	0.000981	CbGpPWpGaD
Bexarotene—Infection—Prednisone—systemic lupus erythematosus	4.49e-05	0.000297	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.48e-05	0.000296	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.48e-05	0.000296	CcSEcCtD
Bexarotene—Back pain—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000296	CcSEcCtD
Bexarotene—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.47e-05	0.000296	CcSEcCtD
Bexarotene—Fatigue—Betamethasone—systemic lupus erythematosus	4.47e-05	0.000295	CcSEcCtD
Bexarotene—Fatigue—Dexamethasone—systemic lupus erythematosus	4.47e-05	0.000295	CcSEcCtD
Bexarotene—Shock—Prednisone—systemic lupus erythematosus	4.45e-05	0.000294	CcSEcCtD
Bexarotene—Pain—Dexamethasone—systemic lupus erythematosus	4.44e-05	0.000293	CcSEcCtD
Bexarotene—Pain—Betamethasone—systemic lupus erythematosus	4.44e-05	0.000293	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	4.43e-05	0.000967	CbGpPWpGaD
Bexarotene—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.43e-05	0.000293	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—systemic lupus erythematosus	4.41e-05	0.000291	CcSEcCtD
Bexarotene—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.41e-05	0.000291	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—systemic lupus erythematosus	4.39e-05	0.00029	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.39e-05	0.000957	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.37e-05	0.000289	CcSEcCtD
Bexarotene—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.36e-05	0.000288	CcSEcCtD
Bexarotene—RXRG—Gene Expression—VDR—systemic lupus erythematosus	4.36e-05	0.000951	CbGpPWpGaD
Bexarotene—Vomiting—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000287	CcSEcCtD
Bexarotene—Rash—Cyclosporine—systemic lupus erythematosus	4.31e-05	0.000285	CcSEcCtD
Bexarotene—Anorexia—Prednisone—systemic lupus erythematosus	4.31e-05	0.000285	CcSEcCtD
Bexarotene—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.3e-05	0.000284	CcSEcCtD
Bexarotene—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.3e-05	0.000284	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000284	CcSEcCtD
Bexarotene—Headache—Cyclosporine—systemic lupus erythematosus	4.28e-05	0.000283	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.28e-05	0.000934	CbGpPWpGaD
Bexarotene—Anaemia—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000283	CcSEcCtD
Bexarotene—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.28e-05	0.000282	CcSEcCtD
Bexarotene—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.000282	CcSEcCtD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	4.27e-05	0.000932	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.24e-05	0.00028	CcSEcCtD
Bexarotene—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.24e-05	0.00028	CcSEcCtD
Bexarotene—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.24e-05	0.00028	CcSEcCtD
Bexarotene—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.21e-05	0.000278	CcSEcCtD
Bexarotene—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.2e-05	0.000278	CcSEcCtD
Bexarotene—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.2e-05	0.000278	CcSEcCtD
Bexarotene—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.2e-05	0.000277	CcSEcCtD
Bexarotene—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.18e-05	0.000276	CcSEcCtD
Bexarotene—Malaise—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000276	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000275	CcSEcCtD
Bexarotene—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.16e-05	0.000274	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—systemic lupus erythematosus	4.14e-05	0.000274	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.12e-05	0.000272	CcSEcCtD
Bexarotene—Dizziness—Prednisolone—systemic lupus erythematosus	4.11e-05	0.000272	CcSEcCtD
Bexarotene—Asthenia—Triamcinolone—systemic lupus erythematosus	4.1e-05	0.000271	CcSEcCtD
Bexarotene—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.1e-05	0.000271	CcSEcCtD
Bexarotene—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.1e-05	0.000271	CcSEcCtD
Bexarotene—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.1e-05	0.000271	CcSEcCtD
Bexarotene—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.1e-05	0.000271	CcSEcCtD
Bexarotene—RXRB—Gene Expression—VDR—systemic lupus erythematosus	4.1e-05	0.000894	CbGpPWpGaD
Bexarotene—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.09e-05	0.00027	CcSEcCtD
Bexarotene—Insomnia—Prednisone—systemic lupus erythematosus	4.09e-05	0.00027	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	4.07e-05	0.000888	CbGpPWpGaD
Bexarotene—Nausea—Cyclosporine—systemic lupus erythematosus	4.06e-05	0.000268	CcSEcCtD
Bexarotene—Paraesthesia—Prednisone—systemic lupus erythematosus	4.06e-05	0.000268	CcSEcCtD
Bexarotene—Pruritus—Triamcinolone—systemic lupus erythematosus	4.05e-05	0.000267	CcSEcCtD
Bexarotene—Cough—Methotrexate—systemic lupus erythematosus	4.04e-05	0.000267	CcSEcCtD
Bexarotene—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.04e-05	0.000267	CcSEcCtD
Bexarotene—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.02e-05	0.000265	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	4e-05	0.000873	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	3.99e-05	0.000871	CbGpPWpGaD
Bexarotene—Dyspepsia—Prednisone—systemic lupus erythematosus	3.98e-05	0.000263	CcSEcCtD
Bexarotene—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.96e-05	0.000262	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—systemic lupus erythematosus	3.94e-05	0.00026	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—systemic lupus erythematosus	3.94e-05	0.00026	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—systemic lupus erythematosus	3.94e-05	0.00026	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—systemic lupus erythematosus	3.93e-05	0.000259	CcSEcCtD
Bexarotene—RXRG—Gene Expression—NR3C1—systemic lupus erythematosus	3.92e-05	0.000856	CbGpPWpGaD
Bexarotene—Rash—Prednisolone—systemic lupus erythematosus	3.92e-05	0.000259	CcSEcCtD
Bexarotene—Dermatitis—Prednisolone—systemic lupus erythematosus	3.92e-05	0.000259	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.91e-05	0.000258	CcSEcCtD
Bexarotene—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.9e-05	0.000258	CcSEcCtD
Bexarotene—Fatigue—Prednisone—systemic lupus erythematosus	3.9e-05	0.000257	CcSEcCtD
Bexarotene—Headache—Prednisolone—systemic lupus erythematosus	3.9e-05	0.000257	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—systemic lupus erythematosus	3.89e-05	0.000257	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—JAK1—systemic lupus erythematosus	3.87e-05	0.000845	CbGpPWpGaD
Bexarotene—Constipation—Prednisone—systemic lupus erythematosus	3.86e-05	0.000255	CcSEcCtD
Bexarotene—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.000255	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.86e-05	0.000841	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.85e-05	0.000839	CbGpPWpGaD
Bexarotene—Rash—Hydrocortisone—systemic lupus erythematosus	3.83e-05	0.000253	CcSEcCtD
Bexarotene—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.83e-05	0.000253	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—systemic lupus erythematosus	3.81e-05	0.000252	CcSEcCtD
Bexarotene—Headache—Hydrocortisone—systemic lupus erythematosus	3.8e-05	0.000251	CcSEcCtD
Bexarotene—Dizziness—Triamcinolone—systemic lupus erythematosus	3.78e-05	0.00025	CcSEcCtD
Bexarotene—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.77e-05	0.000249	CcSEcCtD
Bexarotene—Infection—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000248	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.72e-05	0.000246	CcSEcCtD
Bexarotene—Asthenia—Betamethasone—systemic lupus erythematosus	3.72e-05	0.000246	CcSEcCtD
Bexarotene—Asthenia—Dexamethasone—systemic lupus erythematosus	3.72e-05	0.000246	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000245	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000244	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.7e-05	0.000244	CcSEcCtD
Bexarotene—Nausea—Prednisolone—systemic lupus erythematosus	3.69e-05	0.000244	CcSEcCtD
Bexarotene—RXRB—Gene Expression—NR3C1—systemic lupus erythematosus	3.69e-05	0.000804	CbGpPWpGaD
Bexarotene—Pruritus—Dexamethasone—systemic lupus erythematosus	3.67e-05	0.000242	CcSEcCtD
Bexarotene—Pruritus—Betamethasone—systemic lupus erythematosus	3.67e-05	0.000242	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—systemic lupus erythematosus	3.67e-05	0.000242	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000241	CcSEcCtD
Bexarotene—Vomiting—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.00024	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—IL6—systemic lupus erythematosus	3.63e-05	0.000792	CbGpPWpGaD
Bexarotene—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.00024	CcSEcCtD
Bexarotene—Nausea—Hydrocortisone—systemic lupus erythematosus	3.61e-05	0.000238	CcSEcCtD
Bexarotene—Rash—Triamcinolone—systemic lupus erythematosus	3.61e-05	0.000238	CcSEcCtD
Bexarotene—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.6e-05	0.000238	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—systemic lupus erythematosus	3.6e-05	0.000238	CcSEcCtD
Bexarotene—Rash—Methylprednisolone—systemic lupus erythematosus	3.6e-05	0.000238	CcSEcCtD
Bexarotene—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.59e-05	0.000237	CcSEcCtD
Bexarotene—Headache—Triamcinolone—systemic lupus erythematosus	3.58e-05	0.000237	CcSEcCtD
Bexarotene—Headache—Methylprednisolone—systemic lupus erythematosus	3.57e-05	0.000236	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—systemic lupus erythematosus	3.57e-05	0.000236	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—systemic lupus erythematosus	3.57e-05	0.000236	CcSEcCtD
Bexarotene—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.55e-05	0.000235	CcSEcCtD
Bexarotene—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.55e-05	0.000235	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.54e-05	0.000772	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000227	CcSEcCtD
Bexarotene—Dizziness—Betamethasone—systemic lupus erythematosus	3.43e-05	0.000227	CcSEcCtD
Bexarotene—Dizziness—Dexamethasone—systemic lupus erythematosus	3.43e-05	0.000227	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000226	CcSEcCtD
Bexarotene—Nausea—Triamcinolone—systemic lupus erythematosus	3.4e-05	0.000224	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000224	CcSEcCtD
Bexarotene—Nausea—Methylprednisolone—systemic lupus erythematosus	3.39e-05	0.000224	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.37e-05	0.000222	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000222	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.33e-05	0.00022	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.32e-05	0.00022	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.3e-05	0.000721	CbGpPWpGaD
Bexarotene—Vomiting—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000218	CcSEcCtD
Bexarotene—Vomiting—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000218	CcSEcCtD
Bexarotene—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.28e-05	0.000217	CcSEcCtD
Bexarotene—Rash—Dexamethasone—systemic lupus erythematosus	3.27e-05	0.000216	CcSEcCtD
Bexarotene—Rash—Betamethasone—systemic lupus erythematosus	3.27e-05	0.000216	CcSEcCtD
Bexarotene—RXRA—Metabolism—NAT2—systemic lupus erythematosus	3.27e-05	0.000713	CbGpPWpGaD
Bexarotene—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.27e-05	0.000216	CcSEcCtD
Bexarotene—Dermatitis—Betamethasone—systemic lupus erythematosus	3.27e-05	0.000216	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.26e-05	0.000215	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—systemic lupus erythematosus	3.26e-05	0.000215	CcSEcCtD
Bexarotene—Headache—Dexamethasone—systemic lupus erythematosus	3.25e-05	0.000215	CcSEcCtD
Bexarotene—Headache—Betamethasone—systemic lupus erythematosus	3.25e-05	0.000215	CcSEcCtD
Bexarotene—Asthenia—Prednisone—systemic lupus erythematosus	3.24e-05	0.000214	CcSEcCtD
Bexarotene—Pain—Methotrexate—systemic lupus erythematosus	3.23e-05	0.000213	CcSEcCtD
Bexarotene—Pruritus—Prednisone—systemic lupus erythematosus	3.2e-05	0.000211	CcSEcCtD
Bexarotene—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000206	CcSEcCtD
Bexarotene—Diarrhoea—Prednisone—systemic lupus erythematosus	3.09e-05	0.000204	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	3.09e-05	0.000674	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.09e-05	0.000204	CcSEcCtD
Bexarotene—Nausea—Betamethasone—systemic lupus erythematosus	3.08e-05	0.000204	CcSEcCtD
Bexarotene—Nausea—Dexamethasone—systemic lupus erythematosus	3.08e-05	0.000204	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PPARG—systemic lupus erythematosus	3.04e-05	0.000663	CbGpPWpGaD
Bexarotene—Dizziness—Prednisone—systemic lupus erythematosus	2.99e-05	0.000197	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000197	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000197	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—PPARG—systemic lupus erythematosus	2.91e-05	0.000635	CbGpPWpGaD
Bexarotene—Vomiting—Prednisone—systemic lupus erythematosus	2.87e-05	0.00019	CcSEcCtD
Bexarotene—RXRB—Gene Expression—PPARG—systemic lupus erythematosus	2.86e-05	0.000623	CbGpPWpGaD
Bexarotene—Rash—Prednisone—systemic lupus erythematosus	2.85e-05	0.000188	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—systemic lupus erythematosus	2.85e-05	0.000188	CcSEcCtD
Bexarotene—Headache—Prednisone—systemic lupus erythematosus	2.83e-05	0.000187	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000184	CcSEcCtD
Bexarotene—Asthenia—Methotrexate—systemic lupus erythematosus	2.71e-05	0.000179	CcSEcCtD
Bexarotene—RXRA—Gene Expression—JUNB—systemic lupus erythematosus	2.69e-05	0.000587	CbGpPWpGaD
Bexarotene—Nausea—Prednisone—systemic lupus erythematosus	2.68e-05	0.000177	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000176	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.64e-05	0.000576	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.6e-05	0.000567	CbGpPWpGaD
Bexarotene—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000171	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—TYK2—systemic lupus erythematosus	2.55e-05	0.000556	CbGpPWpGaD
Bexarotene—Dizziness—Methotrexate—systemic lupus erythematosus	2.5e-05	0.000165	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000159	CcSEcCtD
Bexarotene—Rash—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000157	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000157	CcSEcCtD
Bexarotene—Headache—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000156	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.34e-05	0.00051	CbGpPWpGaD
Bexarotene—Nausea—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000148	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.22e-05	0.000485	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—VDR—systemic lupus erythematosus	2.13e-05	0.000466	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.04e-05	0.000446	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—systemic lupus erythematosus	2.01e-05	0.000438	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR3C1—systemic lupus erythematosus	1.92e-05	0.000419	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EP300—systemic lupus erythematosus	1.9e-05	0.000415	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—systemic lupus erythematosus	1.8e-05	0.000393	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.7e-05	0.000371	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—systemic lupus erythematosus	1.65e-05	0.000361	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—systemic lupus erythematosus	1.55e-05	0.000337	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.54e-05	0.000335	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—systemic lupus erythematosus	1.49e-05	0.000325	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—systemic lupus erythematosus	1.25e-05	0.000272	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.22e-05	0.000266	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—systemic lupus erythematosus	1.16e-05	0.000253	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—systemic lupus erythematosus	1.04e-05	0.000227	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—systemic lupus erythematosus	9.95e-06	0.000217	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.7e-06	0.000212	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—systemic lupus erythematosus	9.1e-06	0.000199	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.72e-06	0.00019	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	8.05e-06	0.000176	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.63e-06	0.000167	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—EP300—systemic lupus erythematosus	7.57e-06	0.000165	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	6.84e-06	0.000149	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.35e-06	0.000138	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.51e-06	9.85e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	4.32e-06	9.43e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.88e-06	8.48e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.72e-06	8.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	3.4e-06	7.42e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.85e-06	6.22e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.83e-06	6.17e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.56e-06	5.59e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.45e-06	5.35e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.24e-06	4.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.86e-06	4.07e-05	CbGpPWpGaD
